Federated Hermes, Inc. Solid Biosciences Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.49 - $5.51 $19,568 - $30,894	-5,607 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$5.37 - $10.72 $30,109 - $60,107	5,607 New	5,607 $31,000
Q4 2020 Feb 12, 2021	SELL	$3.08 - $7.79 $351 - $888	-114 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$2.02 - $3.08 $230 - $351	114 New	114 $1,000
Q1 2020 May 13, 2020	SELL	$2.31 - $4.43 $226 - $434	-98 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $276 - $1,264	98 New	98 $1,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.